Pfizer reported lower 3rd quarter profits on Tuesday, October 27, as COVID-19 dented demand for some medicines from patients whose regular healthcare patterns were disrupted.
The company saw an 11% drop in its hospital business in emerging markets, primarily due to fewer elective surgeries in China and shorter in-patient hospital stays in the country.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: